Skip to content

Scholar Rock SRRK Book value per share

Book value per share at other companies

Biogen logo
BiogenBIIB
$125.69+8.5%
PTC Therapeutics logo
PTC TherapeuticsPTCT
-$2.19-1.7%
Travere Therapeutics, Inc. logo
Travere Therapeutics, Inc.TVTX
$1.07+189%
Cogent Biosciences, Inc. logo
Cogent Biosciences, Inc.COGT
$3.75+93.9%
BridgeBio Pharma logo
BridgeBio PharmaBBIO
-$11.70-34.9%
Arrowhead Research logo
Arrowhead ResearchARWR
$4.31-15.2%

Other financials

Income statement

See full
Revenue-
Operating income-$102.0M-32.3%
Net income-$105.5M-41.2%
EPS (diluted)-$0.83-23.9%

Balance sheet

See full
Cash & equivalents$430.5M+212%
Total debt$205.7M+226%
Total equity$276.0M-11.6%
Total assets$535.3M+31.3%

Cash flow

See full
Operating cash flow-$82.1M-4.4%
CapEx$68.0K-74.9%
Free cash flow-$82.2M-4.1%

Valuation

See full
Market cap$5.67B+85.5%
Enterprise value$5.45B+82.6%
P/S170.9×

Profitability

See full
Operating margin-231.8%
Net margin-236.9%
FCF margin-309.1%

Returns & leverage

See full
Return on equity-138.9%+60.1pp
Debt / equity0.7×+0.5×
Current ratio8.6×-1.6×

Where this comes from

Calculated from Scholar Rock’s reported figures.

Based on the most recent quarter.

The official record: Scholar Rock’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Scholar Rock's book value per share.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Scholar Rock's book value per share?
Scholar Rock (SRRK) reported book value per share of $2.17 in Q1 2026.
How has Scholar Rock's book value per share changed year-over-year?
Scholar Rock's book value per share decreased by 22.3% year-over-year, from $2.79 to $2.17.
What is the long-term trend for Scholar Rock's book value per share?
Over 5 years (2020 to 2025), Scholar Rock's book value per share has grown at a -24.1% compound annual growth rate (CAGR), from $8.48 to $2.14.
What does book value per share mean?
Shareholders' equity divided by diluted shares outstanding at the quarter end. The accounting (book) value attributable to each share.